Physiological and clinically attainable concentrations of 1,25-dihydroxyvitamin D3 suppress proliferation and extracellular matrix protein expression in mouse pancreatic stellate cells

被引:17
作者
Blauer, Merja [1 ]
Sand, Juhani [1 ,2 ]
Laukkarinen, Johanna [1 ,2 ]
机构
[1] Tampere Univ Hosp, Tampere Pancreas Lab, FIN-33521 Tampere, Finland
[2] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, FIN-33521 Tampere, Finland
关键词
Collagen; Exocrine pancreas; Fibronectin; VDR; Vitamin D; Pancreatic stellate cells; PHASE-I TRIAL; VITAMIN-D; CALCITRIOL; FIBROSIS; DIFFERENTIATION; IDENTIFICATION; SENESCENCE; CULTURE;
D O I
10.1016/j.pan.2015.05.044
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/objectives: Vitamin D is an antiproliferative and differentiation-promoting secosteroid hormone with pleiotropic homeostatic functions in bone and extraskeletal tissues. Signaling of vitamin D is mediated via its ubiquitously expressed nuclear receptor, the vitamin D receptor (VDR). Pancreatic stellate cells have recently been identified as targets of vitamin D action. Our aim was to elucidate the effectiveness of the most potent endogenous vitamin D metabolite, 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] on the proliferation and extracellular matrix (ECM) protein expression in pancreatic stellate cells (PSCs) using concentrations of the compound from the physiological and clinically attainable range in humans. Methods: Culture-activated mouse PSCs were exposed to 1,25(OH)(2)D-3 concentrations ranging from 0.1 nM to 10 nM for 7 days and subjected to calorimetric crystal violet assay for cell growth assessment and to Western blot and immunohistochemical analyses of VDR, fibronectin and collagen I using protein-specific antibodies. Immunohistochemical localization of VDR was performed on mouse pancreatic tissue and on a set of human specimens obtained at pancreatic surgery. Results: A low basal level of VDR was detected in PSCs that was strongly induced in the presence of ligand. Cell growth was suppressed dose-dependently by 1,25(OH)(2)D-3, the mean percentages of inhibition ranging from 24% at the physiological 0.1 nM concentration to around 60% at 10 nM. Significant 48% and 40% reductions in fibronectin expression were seen at 0.5 nM and I nM 1,25(OH)(2)D-3. A minor decrease in collagen I expression was detected at 5 nM. VDR was predominantly localized in the islets of Langerhans in mouse and human tissues. In the latter VDR was expressed also in the exocrine tissue showing individual variation in its cellular distribution. Conclusions: Mouse PSCs express VDR protein and are sensitive 1,25(OH)(2)D-3 target cells with low levels of 1,25(OH)(2)D-3 exerting antiproliferative and antifibrotic effects on activated PSCs in vitro. Copyright (C) 2015, LAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.
引用
收藏
页码:366 / 371
页数:6
相关论文
共 34 条
  • [1] Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
    Abramovitch, Shirley
    Dahan-Bachar, Liora
    Sharvit, Efrat
    Weisman, Yosef
    Ben Tov, Amir
    Brazowski, Eli
    Reif, Shimon
    [J]. GUT, 2011, 60 (12) : 1728 - 1737
  • [2] Update in Vitamin D
    Adams, John S.
    Hewison, Martin
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) : 471 - 478
  • [3] Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis
    Alvarez, Jessica A.
    Ashraf, Ambika
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2010, 2010
  • [4] Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture
    Apte, MV
    Haber, PS
    Applegate, TL
    Norton, ID
    McCaughan, GW
    Korsten, MA
    Pirola, RC
    Wilson, JS
    [J]. GUT, 1998, 43 (01) : 128 - 133
  • [5] Apte MV, FRONT PHYSL, V3
  • [6] Identification, culture, and characterization of pancreatic stellate cells in rats and humans
    Bachem, MG
    Schneider, E
    Gross, H
    Weidenbach, H
    Schmid, RM
    Menke, A
    Siech, M
    Beger, H
    Grünert, A
    Adler, G
    [J]. GASTROENTEROLOGY, 1998, 115 (02) : 421 - 432
  • [7] Beer TM, 2001, CANCER-AM CANCER SOC, V91, P2431, DOI 10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.3.CO
  • [8] 2-V
  • [9] Beer TM, 2001, SEMIN ONCOL, V28, P49, DOI 10.1016/S0093-7754(01)90155-1
  • [10] Beilfuss A, GUT, V64